Citi Pharma earns Rs833m in FY24

News Image

MG News | October 02, 2024 at 09:22 AM GMT+05:00

0:00

October 02, 2024 (MLN): Citi Pharma Ltd. (PSX: CPHL) earned a net profit of Rs833.46 million in the financial year 2024, translating into earnings per share (EPS) of Rs3.65.

That is up 26.7% from the profit of Rs657.98m [EPS: Rs2.88] recorded in FY23. The increase was in part led by higher margins and other income.

Along with the results, the company announced a final cash dividend of Rs3.25 per share, i.e. 32.5%.

Going by the results, the company's revenue remained largely stable at Rs12.41bn while the cost of sales inched down by 0.6%.

The gross profit improved by 5.3% to Rs1.59bn in FY24. Gross margins rose to 12.8% as compared to 12.2% in SPLY.

During the period under review, other income jumped 67.6% to stand at Rs489.67m in FY24 as compared to Rs292.22m last year.

On the expense side, the company's administrative expenses rose 8.4% from last year to Rs204.14m, selling and distribution expenses rose 16.7% to Rs176.41m, while other operating expenses fell 1.7% to Rs114.2m.

The company’s finance cost decreased by 22.4% and stood at Rs299.91m as compared to Rs386.23m in FY23.

On the tax front, the company paid a higher tax worth Rs447.74m against the Rs299.27m paid in the corresponding period of last year, depicting an increase of 49.6%.

This translates to an effective tax rate of 34.9% as compared to 31.3% in FY23.

Unconsolidated (un-audited) Financial Results for year ended June 30, 2024 (Rupees in '000)
  Jun 24 Jun 23 % Change
Sales 12,409,239 12,396,983 0.10%
Cost of sales (10,823,044) (10,889,870) -0.61%
Gross Profit/ (loss) 1,586,195 1,507,113 5.25%
Administrative Expenses (204,141) (188,414) 8.35%
Selling And Distribution Expenses (176,413) (151,222) 16.66%
Other Income 489,667 292,221 67.57%
Other Operating Expenses (114,201) (116,211) -1.73%
Finance Cost (299,906) (386,234) -22.35%
Profit/ (loss) before taxation 1,281,202 957,254 33.84%
Taxation (447,738) (299,270) 49.61%
Net profit/ (loss) for the period 833,464 657,984 26.67%
Basic earnings/ (loss) per share 3.65 2.88 -

Amount in thousand except for EPS

Copyright Mettis Link News

Related News

Name Price/Vol %Chg/NChg
KSE100 152,740.38
147.44M
-1.01%
-1551.88
ALLSHR 91,858.47
324.25M
-0.86%
-800.10
KSE30 46,223.61
86.89M
-1.45%
-681.25
KMI30 219,130.92
66.08M
-1.15%
-2553.50
KMIALLSHR 59,625.28
139.61M
-0.93%
-562.17
BKTi 42,104.46
39.09M
-2.02%
-866.56
OGTi 32,077.87
10.13M
-1.27%
-414.19
Symbol Bid/Ask High/Low
Name Last High/Low Chg/%Chg
BITCOIN FUTURES 71,105.00 71,860.00
67,460.00
885.00
1.26%
BRENT CRUDE 100.44 114.43
96.00
-11.75
-10.47%
RICHARDS BAY COAL MONTHLY 99.40 0.00
0.00
-12.60
-11.25%
ROTTERDAM COAL MONTHLY 123.30 123.30
123.30
1.70
1.40%
USD RBD PALM OLEIN 1,083.50 1,083.50
1,083.50
0.00
0.00%
CRUDE OIL - WTI 88.72 101.67
84.37
-9.51
-9.68%
SUGAR #11 WORLD 15.52 15.75
15.38
-0.18
-1.15%

Chart of the Day


Latest News
March 23, 2026 at 05:01 PM GMT+05:00

Middle East conflict triggers global policy shift


March 23, 2026 at 04:43 PM GMT+05:00

Iran tensions ease on Trump's latest social media post


March 23, 2026 at 01:34 PM GMT+05:00

Govt increases high-octane levy, drives shift to PHEVs


March 22, 2026 at 02:19 PM GMT+05:00

Key Pakistan Market Stats and Economic Indicators


March 21, 2026 at 12:59 AM GMT+05:00

PM keeps petrol prices unchanged



Top 5 things to watch in this week

Pakistan Stock Movers
Name Last Chg/%Chg
Name Last Chg/%Chg